21 recruiting, 11 completed, 7 active not recruiting, 3 not yet recruiting. 16 Not applicable, 10 Phase 2, 3 Phase 3.
Follow Breast Cancer Invasive: new trials by email Literature Review of Breast Cancer Invasive trials Research Report on Breast Cancer Invasive
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Association Between Blood Routine Parameters and Breast Cancer Prognosis blood routine test - Breast Cancer Invasive | Active not recruiting | Wenjin Yin | 2946 | 2026-05-01 | 2026-05-13 | |
| The Association of Lunula Status With the Efficacy and Safety of Neoadjuvant Therapy in Breast Cancer neoadjuvant therapy - Breast Cancer Invasive | Active not recruiting | Wenjin Yin | 188 | 2026-05-01 | 2026-05-15 | |
| Neoadjuvant, SBRT With Intratumoural Pembrolizumab Followed by Neoadjuvant Chemotherapy in Breast Cancer Radiation, Pembrolizumab (KEYTRUDA®) - Breast Cancer, Breast Cancer Stage II | Phase 2 | Recruiting | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 40 | 2026-01-19 | 2026-02-11 |
| ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE) - iSono Health ATUSA 3D Automated Breast Ultrasound System - Breast Cancer, Benign Breast Condition | Recruiting | iSono Health, Inc. | 800 | 2025-12-16 | 2026-09-17 | |
| Fast and Accurate Breast Cancer Diagnosis Using Nanopore Sequencing in Tanzania (Fast-ABCD Sequencing) Breast Cancer Invasive | Recruiting | University of Bonn | 100 | 2025-09-30 | 2026-10-16 | |
| The Association Between Axillary Lymph Node Metastasis Patterns and Breast Cancer Prognosis ALND - Breast Cancer Invasive | Active not recruiting | Wenjin Yin | 2467 | 2025-09-28 | 2026-05-13 | |
| Role of Triggering Receptor Expressed on Myeloid Cells (TREM-1) as a Novel Biomarker in Human Epidermal Growth Factor Receptor -2 (HER-2) Negative Breast Cancer: a Molecular and Clinical Study Breast Cancer Stage I, Breast Cancer Stage II | Not yet recruiting | Rahma Esam Salama Esawi | 1 | 2025-09-15 | 2025-04-30 | |
| Supermicrosurgical Lymphaticovenous Anastomosis for Prevention of Upper Limb Lymphedema Immediate Distal Lymphaticovenous Anastomosis (ID-LVA) - Breast Cancer-Related Lymphedema, Lymphedema | Not applicable | Not yet recruiting | Tianjin Medical University Cancer Institute and Hospital | 120 | 2025-07-01 | 2025-06-18 |
| Confocal Histolog Scanner in Routine Breast-Conserving Surgery (CHiB) Histolog Scanner - Breast Cancer Invasive, Breast Cancer Surgery | Not applicable | Recruiting | University of Fribourg | 100 | 2025-06-01 | 2025-11-25 |
| A Phase II Clinical Trial of Artificial Intelligence-assisted One-stop Radiotherapy for Breast Cancer After Breast-conserving Surgery ALL-in-one radiotherapy, IMRT - Breast Cancer Invasive | Not applicable | Recruiting | Sun Yat-sen University | 860 | 2025-04-06 | 2025-07-01 |
| Evaluation of Circulating Tumor Cells (CTC) Relevance in Breast Cancer Follow-up Using the ScreenCell Device The DM/DIV ScreenCell is the experimental product studied during this research - Breast Cancer, Metastatic, Breast Cancer Invasive | Not applicable | Recruiting | ScreenCell | 93 | 2025-02-24 | 2026-04-24 |
| Neoadjuvant Treatment of Triple-Negative Breast Cancer with Stereotactic Radiotherapy, PD-1 Monoclonal Antibody, and Chemotherapy neoadjuvant SBRT combined with PD-1 monoclonal antibody and chemotherapy - Breast Cancer Invasive | Phase 2 | Not yet recruiting | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 20 | 2025-02-01 | 2025-02-20 |
| NabPE With or Without Serplulimab for Early-stage HR+/HER2- Breast Cancer. Serplulimab, NabPE - Breast Cancer Invasive | Recruiting | Henan Cancer Hospital | 709 | 2024-12-04 | 2025-06-23 | |
| Diagnostic Performance of [18F]FES PET/CT for Axillary LN Metastasis in ER-positive Breast Cancer Fluoroestradiol (18F) - Breast Cancer Invasive | Phase 2 | Completed | Asan Medical Center | 71 | 2024-11-18 | 2025-12-02 |
| GzmB-PET/CT to Evaluate Neoadjuvant Therapy Efficacy in Breast Cancer 68Ga-GZMB PET/CT - Breast Cancer Invasive | Recruiting | Shanghai Jiao Tong University School of Medicine | 50 | 2024-11-01 | 2024-12-10 | |
| Exploring the Tumor Micro-Environment with 68Ga-FAPi-46 PET/CT in Breast Cancer 68Ga-FAPi-46 PET/CT - Breast Cancer Invasive, Node Positive Breast Cancer | Not applicable | Recruiting | European Institute of Oncology | 92 | 2024-11-01 | 2025-01-27 |
| Precision Regional Node Irradiation for Sentinel Node-positive Breast Cancer SLND(clinical low risk), SLND(clinical high risk, genomic low risk), SLND alone ,clinical high risk and genomic high risk group - Breast Cancer Invasive | Not applicable | Active not recruiting | Ruijin Hospital | 205 | 2024-10-01 | 2026-08-11 |
| Receptive Music Therapy Effects on Anxiety, Depression, QoL, and EGF, IL-8, and NfL During the Breast Cancer Treatment. Music intervention - Breast Cancer Invasive, Chemotherapy | Not applicable | Enrolling by invitation | Brigita Vilc | 90 | 2024-10-01 | 2026-03-19 |
| Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy Tart Cherry Juice - Breast Cancer, Breast Cancer Stage I | Phase 2 | Recruiting | University of California, Davis | 86 | 2024-08-15 | 2026-03-04 |
| Long-Term Outcomes of Endoscopic-assisted vs Conventional Breast-conserving Surgery in Breast Cancer Patients After Neoadjuvant Therapy: a Randomized, Multicenter, Open Label, Non-inferiority Trial Surgery - Breast Cancer Invasive | Not applicable | Recruiting | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 804 | 2024-08-01 | 2026-09-30 |
Showing 20 of 46. Sign in to see all of them.
Breast Neoplasms (26) · Triple Negative Breast Neoplasms (4) · Breast Carcinoma In Situ (3) · Neoplasm Metastasis (2) · Ovarian Neoplasms (2) · Adenocarcinoma of Lung (1) · Adrenocortical Carcinoma (1) · Anisomastia (1) · Anxiety Disorders (1) · Biliary Tract Neoplasms (1) · Breast Cancer Lymphedema (1) · Breast Diseases (1) · Carcinoma, Intraductal, Noninfiltrating (1) · Carcinoma, Non-Small-Cell Lung (1) · Cholangiocarcinoma (1)
Neoplasms (30) · Neoplasms by Site (29) · Skin Diseases (28) · Skin and Connective Tissue Diseases (28) · Breast Diseases (26) · Neoplasms by Histologic Type (6) · Neoplasms, Glandular and Epithelial (6) · Pathological Conditions, Signs and Symptoms (6) · Carcinoma (5) · Carcinoma in Situ (4) · Pathologic Processes (4) · Genital Diseases (3) · Urogenital Diseases (3) · Urogenital Neoplasms (3) · Adenocarcinoma (2)
Surgical Procedures, Operative (3) · pyrotinib (3) · Cyclophosphamide (2) · Doxorubicin (2) · Mastectomy (2) · Paclitaxel (2) · Trastuzumab (2) · pembrolizumab (2) · pertuzumab (2) · 130-nm albumin-bound paclitaxel (1) · Azacitidine (1) · Blood Cell Count (1) · Blood Specimen Collection (1) · Carboplatin (1) · Drug Therapy (1)
Wenjin Yin (3) · Seoul National University Hospital (2) · Shanghai Jiao Tong University School of Medicine (2) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (2) · Asan Medical Center (1) · Baylor Breast Care Center (1) · Brigita Vilc (1) · Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1) · Chung Shan Medical University (1) · Columbia University (1) · Emory University (1) · Ente Ospedaliero Ospedali Galliera (1) · European Institute of Oncology (1) · Federico II University (1) · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano (1)
China (11) · United States (8) · Italy (3) · South Korea (3) · Canada (2) · France (2) · Netherlands (2) · United Kingdom (2) · Australia (1) · Belgium (1) · Croatia (1) · Egypt (1) · Kosovo (1) · Pakistan (1) · Sweden (1)
Wenjin Yin (2) · Wenjin Yin, M.D. (2) · Andrea De Censi, MD (1) · Andreas Karakatsanis, MD, PhD (1) · Andrew Green (1) · Besim Sermaxhaj, MD (1) · Bushra Shirazi (1) · Chandler S Cortina (1) · Chang Gong, Prof (1) · Christian Ingvar, Prof (1) · Eve Rodler, MD (1) · Francesco Ceci, MD (1) · G Sonke (1)
PMID 22495696, PMID 25104441, PMID 26175188, PMID 27252076, PMID 31177874, PMID 34956864, PMID 37106164, PMID 38433091, PMID 41483481, PMID 41723472, PMID 42218652, PMID 42307959
P30CA138292 (1), R44CA291498 (1)